Open Access

ARTICLE

Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo

Leonard Lothstein^*, Judith Soberman^†, Deanna Parke^*, Jatin Gandhi^*, Trevor Sweatman^‡, Tiffany Seagroves^*

* Department of Pathology and Laboratory Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA
† Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA
‡ Department of Pharmacology, The University of Tennessee Health Science Center, Memphis, TN, USA